To provide long term capital appreciation.
Name | % Net Assets |
---|---|
ROCHE HLDG GENUSSCHEINE | 5.2% |
VIVENDI | 3.9% |
STATOILHYDRO ASA | 3.7% |
ASTRAZENECA PLC | 3.2% |
ROYAL KPN N.V. | 2.8% |
KONINKLIJKE KPN NV | 2.6% |
FRESENIUS MEDICAL CARE AG & CO.KGAA | 2.5% |
MUNCHENER RUCKVERSICHERUNGS AG | 2.4% |
SWISSCOM AG | 2.3% |
AIR LIQUIDE(L`) | 2.2% |
Key | % Net Assets |
---|---|
![]() |
5.2% |
![]() |
3.9% |
![]() |
3.7% |
![]() |
3.2% |
![]() |
84% |
Date | 09-Apr-2025 |
---|---|
NAV | 250.11p |
Currency | GBP |
Change | -3.80p |
% | -1.50% |
YTD change | -25.53p |
YTD % | -9.26% |
Fund Inception | 19/02/2001 |
---|---|
Fund Manager | Julie Quinn |
TER | 0.85 (31-Jan-2013) |
Minimum Investment | |
---|---|
Initial | £500000 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.11 |
You are here: research